A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Clinical trial NCT04725331 · TERMINATED

Trial details

NCT number: NCT04725331
Sponsor: Transgene
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer Soft Tissue Sarcoma Merkel Cell Carcinoma Melanoma Triple Negative Breast Cancer Non Small Cell Lung Cancer

Start date: 2021-02-25
Primary completion: 2025-10-22
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.